HCW Biologics

HCWBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.324 M

$1.81 -5.24%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$7.96M

Loss-making

Shares outstanding

1,836,324

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#479XORTX TherapeuticsXRTX$3.38M
#480Aptevo TherapeuticsAPVO$3.33M
#481HCW BiologicsHCWB$3.32M
#482RedHill BiopharmaRDHL$3.29M
#483China SXT PharmaceuticalsSXTC$3.26M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of HCW Biologics, worth $100.0K. Grants and option exercises are excluded.

Hing C. WongChief Executive Officer$60.0K
23,210 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026
Scott T. Garrett$20.0K
7,736 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026
Lee FlowersSVP of Business Development$20.0K
7,736 shares at $2.59 on 29 Jul 2026 · filed 31 Jul 2026

What if HCW Biologics were worth as much as…

Open the what-if tool →

Gold $30.2T

$16,464,400

Per share 9,096,354× higher

Bitcoin $1.74T

$948,446.61

Per share 524,004× higher

Nvidia $5.52T

$3,003,701

Per share 1,659,503× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for HCW Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.